Literature DB >> 10401850

Nasal stuffiness during pregnancy.

M Bende1, T Gredmark.   

Abstract

OBJECTIVE: To investigate the occurrence of nasal stuffiness during pregnancy. STUDY
DESIGN: Prospective longitudinal study, with collection of data during 1 year in a cohort of 2,264 pregnant women.
METHODS: Self-reported nasal stuffiness in gestational weeks 12, 20, 30, and 36 was correlated to age, parity, body mass index, and smoking habits.
RESULTS: The prevalence of nasal stuffiness increased during pregnancy and occurred in 27% of the women at 12 weeks of gestation, in 37% at 20 weeks, in 40% at 30 weeks and in 42% at 36 weeks. Sixty-five percent of the women reported stuffiness at some time when asked. It was commoner in multiparous than in nulliparous women. Age, body mass index, and smoking habits were not associated with nasal stuffiness.
CONCLUSION: Self-reported nasal stuffiness for 3 or more weeks was common during pregnancy and could occur at any time in two thirds of the women. Treatment regimens to alleviate this symptom should be developed.

Entities:  

Mesh:

Year:  1999        PMID: 10401850     DOI: 10.1097/00005537-199907000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

Review 1.  Gestational intermittent hypoxia increases susceptibility to neuroinflammation and alters respiratory motor control in neonatal rats.

Authors:  Stephen M Johnson; Karanbir S Randhawa; Jenna J Epstein; Ellen Gustafson; Austin D Hocker; Adrianne G Huxtable; Tracy L Baker; Jyoti J Watters
Journal:  Respir Physiol Neurobiol       Date:  2017-11-22       Impact factor: 1.931

2.  Does menopause effect nasal mucociliary clearance time?

Authors:  Gül Soylu Özler; Ercan Akbay; Ayşe Neslin Akkoca; Oya Soylu Karapınar; Gökçe Özel Şimşek
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-04       Impact factor: 2.503

Review 3.  Safety of intranasal corticosteroid sprays during pregnancy: an updated review.

Authors:  Ahmed H Alhussien; Riyadh A Alhedaithy; Saad A Alsaleh
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-21       Impact factor: 2.503

Review 4.  Sleep disordered breathing and pregnancy.

Authors:  N Edwards; P G Middleton; D M Blyton; C E Sullivan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

5.  Sleep disorders in pregnancy and their association with pregnancy outcomes: a prospective observational study.

Authors:  S K Sharma; A Nehra; S Sinha; M Soneja; K Sunesh; V Sreenivas; D Vedita
Journal:  Sleep Breath       Date:  2015-05-10       Impact factor: 2.816

Review 6.  Clinical and pathogenetic characteristics of pregnancy rhinitis.

Authors:  Eva K Ellegård
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

7.  Validation of the Apnea Risk Evaluation System (ARES) device against laboratory polysomnography in pregnant women at risk for obstructive sleep apnea syndrome.

Authors:  Katherine M Sharkey; Kelly Waters; Richard P Millman; Robin Moore; Susan M Martin; Ghada Bourjeily
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

8.  The prevalence and associated risk factors of sleep disorder-related symptoms in pregnant women in China.

Authors:  Xiao-Hong Cai; Yu-Peng Xie; Xiu-Cui Li; Wang-Lei Qu; Ting Li; Hong-Xia Wang; Jie-Qiang Lv; Liang-Xing Wang
Journal:  Sleep Breath       Date:  2012-11-07       Impact factor: 2.816

Review 9.  Pregnancy and olfaction: a review.

Authors:  E Leslie Cameron
Journal:  Front Psychol       Date:  2014-02-06

Review 10.  Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.

Authors:  Xiaoxuan Zhao; Yuepeng Jiang; Yang Zhao; Hongyan Xi; Chang Liu; Fan Qu; Xiaoling Feng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-23       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.